ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
59 hedge funds and large institutions have $24.9M invested in Zynerba Pharmaceuticals, Inc in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
35% less capital invested
Capital invested by funds: $38.3M → $24.9M (-$13.4M)
Holders
59
Holding in Top 10
–
Calls
$215K
Puts
$120K
Top Buyers
| 1 | +$254K | |
| 2 | +$167K | |
| 3 | +$139K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$129K |
| 5 |
D.E. Shaw & Co
New York
|
+$106K |
Top Sellers
| 1 | -$1.99M | |
| 2 | -$430K | |
| 3 | -$253K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$245K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$185K |